SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : T/FIF, a New Plateau -- Ignore unavailable to you. Want to Upgrade?

To: scaram(o)uche who wrote (100)5/4/2000 2:23:00 PM
From: Mike McFarland  Read Replies (1) | Respond to of 2243
 
No, I'd expect your portfolio to include
precious metals, utilities, and tbills,
teeheehe.

Say, aren't there still a few things from
DAK's old list which were close to book value?
I have a block of Synaptic around here still,
(jeeze, what a dog that was during the correction)
--that one should be somewhere around 2x cash
if I remember right. Haven't looked lately, anybody?



To: scaram(o)uche who wrote (100)5/4/2000 3:37:00 PM
From: nigel bates  Respond to of 2243
 
>>It was just an attempt to make a list of particularly "investment grade" biotechs<<
I would argue for Cambridge Antibody to be added to the list (among others). Actually if you look at its performance against ABGX & MEDX since they all hit the peak, it has held up (relatively) well already.

nig


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News